AIM ImmunoTech Inc (AIM)
0.2635
+0.02
(+8.88%)
USD |
NYAM |
Oct 04, 16:00
0.2676
0.00 (0.00%)
Pre-Market: 20:00
AIM ImmunoTech Shareholders Equity (Annual): 10.23M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.23M |
| December 31, 2022 | 38.47M |
| December 31, 2021 | 56.88M |
| December 31, 2020 | 61.29M |
| December 31, 2019 | 13.44M |
| December 31, 2018 | 5.174M |
| December 31, 2017 | 8.703M |
| December 31, 2016 | 15.50M |
| December 31, 2015 | 20.37M |
| December 31, 2014 | 25.00M |
| December 31, 2013 | 29.30M |
| December 31, 2012 | 44.70M |
| December 31, 2011 | 37.96M |
| December 31, 2010 | 45.95M |
| December 31, 2009 | 58.70M |
| Date | Value |
|---|---|
| December 31, 2008 | 11.54M |
| December 31, 2007 | 20.96M |
| December 31, 2006 | 24.75M |
| December 31, 2005 | 18.63M |
| December 31, 2004 | 21.56M |
| December 31, 2003 | 9.248M |
| December 31, 2002 | 3.63M |
| December 31, 2001 | 10.76M |
| December 31, 2000 | 11.57M |
| December 31, 1999 | 12.70M |
| December 31, 1998 | 15.20M |
| December 31, 1997 | 10.70M |
| December 31, 1996 | 5.90M |
| December 31, 1995 | 4.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
10.23M
Minimum
2023
61.29M
Maximum
2020
36.06M
Average
38.47M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics Inc | 75.18M |
| Protalix BioTherapeutics Inc | 33.57M |
| Electromed Inc | 44.54M |
| Xtant Medical Holdings Inc | 51.35M |
| Armata Pharmaceuticals Inc | -32.06M |